SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21273606
Source:
http://linkedlifedata.com/resource/pubmed/id/21273606
Search
Subject
Predicate
Object
All
(
58
)
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists.
Subject
Predicate
Object
Context
pubmed-article:21273606
rdf:type
pubmed:Citation
lld:pubmed
pubmed-article:21273606
lifeskim:mentions
umls-concept:C0030705
lld:lifeskim
pubmed-article:21273606
lifeskim:mentions
umls-concept:C0007137
lld:lifeskim
pubmed-article:21273606
lifeskim:mentions
umls-concept:C1168401
lld:lifeskim
pubmed-article:21273606
lifeskim:mentions
umls-concept:C0460004
lld:lifeskim
pubmed-article:21273606
lifeskim:mentions
umls-concept:C1522484
lld:lifeskim
pubmed-article:21273606
lifeskim:mentions
umls-concept:C0036525
lld:lifeskim
pubmed-article:21273606
lifeskim:mentions
umls-concept:C0034897
lld:lifeskim
pubmed-article:21273606
lifeskim:mentions
umls-concept:C1706679
lld:lifeskim
pubmed-article:21273606
lifeskim:mentions
umls-concept:C0282460
lld:lifeskim
pubmed-article:21273606
lifeskim:mentions
umls-concept:C2828242
lld:lifeskim
pubmed-article:21273606
pubmed:issue
1
lld:pubmed
pubmed-article:21273606
pubmed:dateCreated
2011-1-28
lld:pubmed
pubmed-article:21273606
pubmed:abstractText
Saracatinib (AZD0530) is an orally available Src kinase inhibitor. A phase II study was conducted to evaluate saracatinib in patients with recurrent or metastatic head and neck squamous cell cancer (HNSCC).
lld:pubmed
pubmed-article:21273606
pubmed:language
eng
lld:pubmed
pubmed-article:21273606
pubmed:journal
http://linkedlifedata.com/r...
lld:pubmed
pubmed-article:21273606
pubmed:citationSubset
IM
lld:pubmed
pubmed-article:21273606
pubmed:chemical
http://linkedlifedata.com/r...
lld:pubmed
pubmed-article:21273606
pubmed:chemical
http://linkedlifedata.com/r...
lld:pubmed
pubmed-article:21273606
pubmed:chemical
http://linkedlifedata.com/r...
lld:pubmed
pubmed-article:21273606
pubmed:status
MEDLINE
lld:pubmed
pubmed-article:21273606
pubmed:month
Jan
lld:pubmed
pubmed-article:21273606
pubmed:issn
1791-7530
lld:pubmed
pubmed-article:21273606
pubmed:author
pubmed-author:PfisterDavid...
lld:pubmed
pubmed-article:21273606
pubmed:author
pubmed-author:ShenRonglaiR
lld:pubmed
pubmed-article:21273606
pubmed:author
pubmed-author:CarlsonDianeD
lld:pubmed
pubmed-article:21273606
pubmed:author
pubmed-author:StambukHildaH
lld:pubmed
pubmed-article:21273606
pubmed:author
pubmed-author:FuryMatthew...
lld:pubmed
pubmed-article:21273606
pubmed:author
pubmed-author:BaxiShrujalS
lld:pubmed
pubmed-article:21273606
pubmed:author
pubmed-author:HaqueSofiaS
lld:pubmed
pubmed-article:21273606
pubmed:author
pubmed-author:KellyKatherin...
lld:pubmed
pubmed-article:21273606
pubmed:author
pubmed-author:LipsonBrynna...
lld:pubmed
pubmed-article:21273606
pubmed:issnType
Electronic
lld:pubmed
pubmed-article:21273606
pubmed:volume
31
lld:pubmed
pubmed-article:21273606
pubmed:owner
NLM
lld:pubmed
pubmed-article:21273606
pubmed:authorsComplete
Y
lld:pubmed
pubmed-article:21273606
pubmed:pagination
249-53
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:meshHeading
pubmed-meshheading:21273606...
lld:pubmed
pubmed-article:21273606
pubmed:year
2011
lld:pubmed
pubmed-article:21273606
pubmed:articleTitle
Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
lld:pubmed
pubmed-article:21273606
pubmed:affiliation
Head and Neck Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
lld:pubmed
pubmed-article:21273606
pubmed:publicationType
Journal Article
lld:pubmed
pubmed-article:21273606
pubmed:publicationType
Clinical Trial, Phase II
lld:pubmed